Innovation Pharmaceuticals Inc (IPIX)

[Brinjal]

The Brilacidin arm and the placebo arm had 60 patients each. 2/3rd (40 patients) in the Brilacidin arm received a 5-day course, and 1/3rd (20 patients) a 3-day course (this was announced previously). 4 in the Brilacidin arm died, and ditto in the placebo arm. That's the reason for the conclusion that there was no change in mortality.

The way the PR is worded is a little confusing.